SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-3.23%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$597M
AUM Growth
+$597M
(-29%)
Cap. Flow
-$210M
Cap. Flow
% of AUM
-35.28%
Top 10 Holdings %
Top 10 Hldgs %
55.79%
Holding
101
New
12
Increased
17
Reduced
23
Closed
38
Top Buys
| 1 |
Novo Nordisk
NVO
|
$26.4M |
| 2 |
Johnson & Johnson
JNJ
|
$24.8M |
| 3 |
Pfizer
PFE
|
$14.8M |
| 4 |
Advanced Micro Devices
AMD
|
$10.9M |
| 5 |
ZIM Integrated Shipping Services
ZIM
|
$10.8M |
Top Sells
| 1 |
AbbVie
ABBV
|
$44.3M |
| 2 |
Eli Lilly
LLY
|
$25.6M |
| 3 |
Microsoft
MSFT
|
$17M |
| 4 |
AstraZeneca
AZN
|
$14.5M |
| 5 |
Amazon
AMZN
|
$14M |
Sector Composition
| 1 | Healthcare | 85.78% |
| 2 | Industrials | 5.11% |
| 3 | Technology | 4.48% |
| 4 | Financials | 1.66% |
| 5 | Communication Services | 1.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Perion Network
PERI
$418M
| $6.88M | 0.97% |
306,051
+81,051
| +36% | +$1.82M |
|
27
Immunic
IMUX
$79.4M
| $6.59M | 0.93% |
583,206
-83,396
| -13% | -$942K |
|
28
VistaGen Therapeutics
VTGN
$113M
| $6.14M | 0.87% |
4,951,423
+926,485
| +23% | +$1.15M |
|
29
Visa
V
$681B
| $5.59M | 0.79% |
+25,200
| New | +$5.59M |
|
30
Airbnb
ABNB
$76.5B
| $5.15M | 0.73% |
30,000
-17,689
| -37% | -$3.04M |
|
31
Immatics
IMTX
$662M
| $4.97M | 0.7% |
621,925
| – | – |
|
32
Sunrun
RUN
$3.8B
| $4.56M | 0.64% |
+150,000
| New | +$4.56M |
|
33
Caesarstone
CSTE
$47.3M
| $4.5M | 0.64% |
428,046
-216,100
| -34% | -$2.27M |
|
34
Mastercard
MA
$536B
| $4.32M | 0.61% |
+12,100
| New | +$4.32M |
|
35
Alnylam Pharmaceuticals
ALNY
$58.6B
| $4.04M | 0.57% |
+24,768
| New | +$4.04M |
|
36
Nautilus Biotechnolgy
NAUT
$80.7M
| $3.65M | 0.52% |
840,000
+40,000
| +5% | +$174K |
|
37
Replimune Group
REPL
$460M
| $3.61M | 0.51% |
+212,640
| New | +$3.61M |
|
38
Fate Therapeutics
FATE
$115M
| $3.47M | 0.49% |
89,425
-96,051
| -52% | -$3.72M |
|
|
VRNA
39
Verona Pharma
VRNA
$9.18B
| $3.33M | 0.47% |
666,339
-134,917
| -17% | -$673K |
|
40
FIVE9
FIVN
$2.05B
| $3.28M | 0.46% |
29,699
-55,857
| -65% | -$6.17M |
|
41
Kezar Life Sciences
KZR
$28.5M
| $3.12M | 0.44% |
187,599
-149,694
| -44% | -$2.49M |
|
42
Ascendis Pharma
ASND
$12.1B
| $3.11M | 0.44% |
+26,529
| New | +$3.11M |
|
|
IS
43
DELISTED
ironSource Ltd.
IS
| $2.98M | 0.42% |
+620,000
| New | +$2.98M |
|
|
VINC
44
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $2.88M | 0.41% |
720,161
| – | – |
|
45
Caterpillar
CAT
$194B
| $2.67M | 0.38% |
+12,000
| New | +$2.67M |
|
46
Werewolf Therapeutics
HOWL
$62.6M
| $2.57M | 0.36% |
584,203
-64,188
| -10% | -$282K |
|
47
SentinelOne
S
$6.01B
| $2.52M | 0.36% |
65,000
-134,824
| -67% | -$5.22M |
|
48
Krystal Biotech
KRYS
$4.35B
| $1.68M | 0.24% |
+25,310
| New | +$1.68M |
|
49
Cyclacel Pharmaceuticals
CYCC
$17.2M
| $1.55M | 0.22% |
508,322
| – | – |
|
|
MGIC
50
Magic Software Enterprises
MGIC
$956M
| $1.4M | 0.2% |
81,293
+23,589
| +41% | +$407K |
|